Correction to: 2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation (Life, (2022), 12, 6, (876), 10.3390/life12060876)

Mohamed H. Elsherbeny, Usama M. Ammar, Magda H. Abdellattif, Mohammed A.S. Abourehab, Ahmed Abdeen, Samah F. Ibrahim, Doaa Abdelrahaman, Wessam Mady, Eun Joo Roh, Ahmed Elkamhawy

Research output: Contribution to journalComment/debate

Abstract

In the original publication [1], reference number 26 [2] was added by mistake. Thus, it was removed. With this correction, the order of some references has been adjusted accordingly. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Original languageEnglish
Article number423
JournalLife
Volume14
Issue number4
DOIs
StatePublished - Apr 2024

Fingerprint

Dive into the research topics of 'Correction to: 2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation (Life, (2022), 12, 6, (876), 10.3390/life12060876)'. Together they form a unique fingerprint.

Cite this